The Government’s 2012-13 budget decision to cut inbound duty-free tobacco sales will help reduce the nation’s cancer burden, according to Cancer Council Australia.

Soybeans soaking in warm water could become a new “green” source for production of a cancer-fighting substance now manufactured in a complicated and time-consuming industrial process, scientists are reporting in ACS’ Journal of Agricultural and Food Chemistry.

With high UV levels continuing in Queensland this autumn, young people are at risk of suffering the worst skin damage they will receive during their lifetime, research from Queensland University of Technology (QUT) has found.

Thousands of Australians will avoid a premature death thanks to $50 million in new funds for bowel cancer screening announced in the lead-up to the federal budget, Cancer Council Australia said today.

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL). The study results are been published on the online edition of the journal Science Translational Medicine.

This Mother’s Day, youth cancer charity CanTeen reaches out to young Australians aged 12-24 who have been devastated by their mum’s cancer diagnosis.

Despite widespread belief to the contrary, as few as 6 percent of women experience cancer-related persistent fatigue a year after undergoing treatment for breast cancer, a new study has found.

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and University of Kentucky have found that breast cancer survivors who have had chemotherapy, radiation or both do not perform as well on some cognitive tests as women who have not had cancer.

Australian women with advanced ovarian cancer have a new treatment option for their disease. The anti-cancer treatment, Avastin (bevacizumab), is now approved by the Therapeutic Goods Administration (TGA) in combination with chemotherapy (carboplatin and paclitaxel) for the treatment of patients with newly diagnosed (first-line) advanced epithelial ovarian, fallopian tube or primary peritoneal ...

A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.